This is your liver. Overview. Functions of the Liver 3/9/2015. This is your liver on Drugs. Drugs and the Liver Drug Induced Liver Injury (DILI)

Size: px
Start display at page:

Download "This is your liver. Overview. Functions of the Liver 3/9/2015. This is your liver on Drugs. Drugs and the Liver Drug Induced Liver Injury (DILI)"

Transcription

1 This is your liver Drugs and the Liver Drug Induced Liver Injury (DILI) Rebecca Duke DNP, MSN, APN-CNP AACN Spring 2015 Transplant Surgery Nurse Practitioner This is your liver on Drugs Overview Over 1000 medications and herbal products have been implicated in DILI 30% of cases of acute hepatitis Cause of jaundice in 50% of patients with new onset jaundice Most common reason for withdrawal of medications The metabolites of compounds are usually the causative factors of DILI Functions of the Liver Liver injury may be produced by a large variety of chemical substances Secretory 1) Bile acid from cholesterol 2)Conjugation of bili Excretory Excretion of exogenous dyes/substa nces Metabolic 1) CHO 2) Lipid 3) Ammonia acid 4) Cholesterol synthesis 5) Mineral 6) Ammonia formation 7) Vitamin 8) Nucleic acid 9) Interconversion of sugars Synthetic Synthesis of 1) Albumin 2) Alpha 1 Gamma globulins 3) Clotting factors 4) Binding proteins 5) Transport Proteins 6) Hormones 7) Cholesterol Detoxification of 1) Xenobiotics 2) Steroids 3) Thyroid hormone 4)Endogenous metabolit es Storage 1) Glycogen 2) B12 3) Vitamin A 4) Copper 5) Iron The type and degree of injury produced is extremely varied, and may mimic the entire spectrum of hepatobiliary disorders The central role played by the liver in the clearance and biotrasnformation of chemicals make the liver susceptible to drug-induced injury. Drugs can initiate progressive chronic liver disease and are the single leading cause of acute liver failure. 1

2 Overview Definitions Type of injury Prescription medications Over the counter Complementary Alternative Medicine (CAM) Illicits Drugs and Disease Drugs in the cirrhotic liver Classification of DILI (drug induced liver injury) Clinical presentation Hepatocellular (cytotoxic) injury Cholestatic injury Mixed injury Mechanisms of hepatotoxicity Intrinsic/Predictable - Tylenol Idiosyncratic only if genetic variable are right Histologic findings Hepatitis Cholestasis Steatosis Hepatocellular Injury AST/ALT elevated Little to no elevation of Alk Phos Ratio helpful ETOH AST:ALT 2:1 Viral hepatitis AST:ALT <1 Common Causes NAFLD/NASH DILI ETOH Hemochromatosis Viral Hepatitis Extrahepatic conditions Cholestatic Injury Lab abnormalities: Alkaline phosphatase, GGT, Total bilirubin elevated Common etiologies Biliary diseases PBC, PSC DILI ETOH hepatitis Hormonal effects on bile flow during pregnancy (cholestasis of pregnancy) Cancer HBV or HCV Cirrhosis (not as common until significant severity) Bile stone/stricture Pancreatic cancer Pharmacology and the Liver Cytochrome P450 system Most drugs are metabolized in the liver Cytochrome P450 system Drug induced pattern Cholestatic, hepatocellular Can cause steatosis Major enzymes involved in drug and bio-activation Inducers and inhibitors Inducers- induces the enzyme Less drug in system Inhibitors inhibits the enzyme More drug in system 2

3 Variables in People for Idiosyncratic DILI Host Factors Environmental Factors Drug-Related Factors Age Smoking Daily Dose Gender Alcohol consumption Metabolic profile Pregnancy Malnutrition Obesity Diabetes Mellitus Co-morbidities including underlying liver disease Indications for therapy Genetics Renal Function Infection and inflammatory episodes Class effect and cross sensitization Drug interactions and polypharmacy Duration of therapy Evaluation of Suspected Idiosyncratic Drug Reactions Hepatitis A, B, C >2 or <5 (mixed) Viral Hepatitis, Autoimmune hepatitis, imaging Abnormal LFTs Thorough H&P Calculate R value >/=5 Hepatocellular Viral Hepatitis, autoimmune hepatitis, imaging </=2 (Cholestatic) Imaging Studies Autoimmune markers: ANA, AMA, SMA Detective Work.Let s put on the hat History is critical Medication history back 2-3 months How long as lab abnormality been noted? How long as jaundice been present Any dark urine? Have they ever been on this medication before? Have they ever had a drug reaction/sensitivity previously? Drugs in same class?? Over the Counters (OTC s) Over the Counter Drugs NSAIDs Acetaminophen Iron supplements Vitamins NSAIDs Those with cirrhosis or advanced liver disease should avoid this class of drugs Hepatitis can occur with variable rates among NSAIDs Diclofenac more common Hepatitis usually resolves after stopping the drug Rare reports of liver failure and chronic liver disease Hepatorenal syndrome Type 1 or type 2 cause renal dysfunction and even renal failure Most common in those with significant hepatic dysfunction/decompensation Block prostaglandins which help with vasodilation Can cause renal problems 3

4 Acetaminophen Okay in liver disease Preferred over NSAIDs No > than 1000 mg/dose No > than 3000 mg/day (FDA says 4000) Conservative dosing recommended no > 2000 mg/day > 3 alcoholic beverages no more than 2000 mg/day Acetaminophen Injury can occur with single dose of 7-10 grams More likely with ingested dosages > 150 mg/kg Children are lower Most recover with supportive measures Need for transplantation Rising INR poor prognostic factor 5% children Therapeutic misadventure More common in elderly, polypharmacy or with OTC combination therapies (cold/uri medication) Iron Supplements Vitamins Hemochromatosis Increased risk for HCC Secondary disease may become exacerbated Those with cirrhosis Overload can cause progression No supplementation unless has IDA Be careful of vitamins with extra iron, prenatal vitamins Vitamin A high doses can be toxic to the liver mild and reversible elevated LFT s Rare liver failure Pre-existing and alcohol = worse Improve with d/c If vitamin deficient Replete and repeat Background In % of U.S. adults reported using natural products Complementary and Alternative Medications (CAM).Herbals etc. Dietary Supplement Health and Education Act (DSHEA) and Final Rule for Dietary Supplement Current Good Manufacturing Practices Does not focus on safety of the ingredients Contains no minimum requirements for quality No responsibility for safety surveillance or reporting to manufacturer 4

5 CAM therapy Reports of acute hepatitis, veno-occlusive disease, fulminant hepatic failure, cirrhosis Interactions more common Not well studied (Traditional FDA trials) Valerian Complementary Alternative Medicine (CAM) Therapies..Not exhaustive in this lecture Black Cohosh Milk Thistle or silymarin Kava Glycyrrhizin (licorice root extract) Diet drugs Hydroxycut, herbalife, Ma Huang liver cleanse Valerian Perennial plant native to Europe Used to treat anxiety, insomnia and nervous restlessness Increases GABA in the brain?? Study found to be no more effective than placebo (14 days) Other studies showed that it can reduce time to fall asleep and improves quality of sleep May effect of drugs in the liver cause toxic levels Statins, antifungal drugs Increase effects of anticonvulsants, barbituates, benzdiazepines, insomnia meds, TCA s and alcohol May effect anesthesia Slows down CNS Black Cohosh Derived from a plant native to N. America Used to treat menopausal symptoms, joint pain, myalgia, bronchitis and obesity Hepatotocixity ranges from autoimmunelike hepatitis to ALF Milk Thistle/Silymarin Anti-oxidant and free-radical scavenger Most commonly utilized for patients in liver disease Thought to have anti-fibrotic activity No side effects Evidence variable Not likely to improve ALT levels JAMA, 2012 Stickel F, Schuppan D. Herbal Medicine in the treatment of liver diseases. Digestive and Liver Disease. 39 (2007)

6 Kava Glycyrrhizin (licorice root extract) Kava root psychotropic remedy in Hawaii, polynesia and the Fiji islands Europe and elsewhere Anxiety disorders Hepatic necrosis or cholestatic hepatitis Can develop fulminant liver failure necessitating liver tx Patients ingesting greater than 250 mg a day of kavalactones are at increased risk Prevents liver injury in animals Anti-oxidant activity Blunts ALT elevations and impedes fibrosis in animals Reported to be beneficial in viral hepatitis Can improve AST/ALT in NAFLD/NASH Single study Comprehensive studies needed Hajiaghamohammadi, A. A., Ziaee, A. and Samimi, R. (2012), The Efficacy of Licorice Root Extract in Decreasing Transaminase Activities in Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. Phytother. Res., 26: doi: /ptr.3728 Diet Drugs Herbalife & Hydroxycut Several case reports of acute liver injury Exact mechanism unknown Necrosis and cholestasis on biopsy Idiosyncratic reaction possible Allergic reaction? Contamination? Hydroxycut 3/8 patients required transplantation No studies done Does not require FDA approval Only case studies Ma Huang ephedra - banned Stickel F, Schuppan D. Herbal Medicine in the treatment of liver diseases. Digestive and Liver Disease. 39 (2007) Chen GC, Ramanathan VS, Law D, Funchain P, Chen GC, French S, Shlopov B, Eysselein V, Reicher S, Pham BV. World J Hepatol November 27; 2(11) ; Am J Gastroenterol 2010;105: ; doi: /ajg ; published online 26 January 2010 Green Tea Extract Dandelion Natural diuretic Stimulates bile flow No evidence for improvement in the liver Used in combo products No proven studies 6

7 Liver Cleanse/Combo CAM Usually combination medications Usually milk thistle Dandelion Other extracts such as artichoke, tumeric etc. Prescription Medications Antibiotics Most reactions are idiosyncratic Tetracyclines and oxypenicillins Usually dose related Erythromycin induced injury usually improves after d/c Sulfamethoxazole Trimethoprim Ampicillin, amoxicillin and Augmentin (amox/clav) Cholestatic and mixed hepatocellular injury Onset of jaundice may be delayed reaction (can happen months after cessation) (Amox/Clav) More Antibiotics Sulfonamides Cholestasis Less common granulomatous hepatitis Hepatocellular necrosis fatal cases Nitrofurantoin Acute and chronic hepatic injury May be immunoallergic or metabolic Fluoroquinolones Macrolides Minocycline Antifungals More common in immunocompromised or on multiple meds Nitrofurantoin Hepatitis Fatigue Fever Muscle and joint aches Poor appetite Nausea/vomiting Weight loss Jaundice Methotrexate At risk populations: Obese Pre-existing liver disease Alcohol Use lower doses Monitor LFT s closely May need to biopsy prior to start of therapy Biopsy may be warranted if half of the monitored LFT s are elevated in one year period Surveillance biopsy after on therapy for a few years 7

8 Tuberculosis Medications Isoniazid % - symptomatic 10-20% elevation of transaminases Histopathology resembles viral hepatitis Resolves 1-4 weeks after d/c Worse with alcohol or concomitant use of acetaminophen or rifampin Rifampin P450 system 1.1% rate of liver toxicity Worse with HCV, HBV, alcoholism Cholestasis, jaundice Tbili up to 30 or more Resolves after d/c Cholestatic injury can take weeks or longer to recover/resolve Statins 0.5-3% have elevated LFT s Can be utilized in those with liver disease CV disease will kill many patients before a mild elevation in their enzymes does anything Monitor LFT s Prior to start of Rx 2-3 months Every 6 months Niacin Anti-Convulsants Can cause mild transaminitis, jaundice and in rare cases liver failure Liver toxicity is dose dependent Toxic doses usually exceed 2 grams per day Worse in those with pre-existing liver disease and alcohol Phenytoin hepatocellular damage rare CYP450 inducer Carbamazepine/Oxcarbazepine liver failure can occur despite d/c Lamotrigine liver failure has been reported in both peds and adults Phenobarbital Valproic acid 20% of patients have elevated LFT s Liver failure more common in children Amiodarone Hydralazine Liver injury ranging from mild transaminase elevations to acute liver failure and cirrhosis Abnormalities usually resolve weeksmonths after stopping meds Significant damage can occur < 1% of patients Used to treat HTN Hepatotoxicity Hypersensitivity-type injury Mixed hepatocellular injury Acute hepatitis Cholestatic jaundice Centrilobular necrosis Reversible after d/c the med 8

9 Illicit Drugs Amphetamines Ecstasy can cause liver failure in severe cases Cocaine ischemic necrosis of the liver Drugs and the Cirrhotic Liver Liver dysfunction causes alterations in clearance May need to adjust dosage Start slow Statins lower doses and monitor LFT s Check enzymes more frequently Anabolic Steroids Not illicit to utilized without indication TPN Drugs and Fatty Liver Disease Methotrexate Tamoxifen Steroids Valprate Amiodarone Questions? Thank you! rduke@nm.org HAART therapy 9

EVALUATION OF ABNORMAL LIVER TESTS

EVALUATION OF ABNORMAL LIVER TESTS EVALUATION OF ABNORMAL LIVER TESTS MIA MANABAT DO PGY6 MOA 119 TH ANNUAL SPRING SCIENTIFIC CONVENTION MAY 19, 2018 EVALUATION OF ABNORMAL LIVER TESTS Review of liver enzymes vs liver function tests Clinical

More information

Diagnostic evaluation of suspected Drug-Induced Liver Injury

Diagnostic evaluation of suspected Drug-Induced Liver Injury Diagnostic evaluation of suspected Drug-Induced Liver Injury Ynto de Boer, MD Department of Gastroenterology and Hepatology Disclosure No disclosures Drug-induced liver injury? Outline What is DILI? What,

More information

Abnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University

Abnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University Abnormal Liver Chemistries Lauren Myers, MMsc. PA-C Oregon Health and Science University Disclosure 1. The speaker/planner Lauren Myers, MMSc, PA-C have no relevant financial relationships to disclose

More information

Drug-induced liver injury

Drug-induced liver injury Drug-induced liver injury Vincent Wong MBChB(Hons), MD, FRCP, FHKCP, FHKAM Professor, Department of Medicine and Therapeutics Director, Cheng Suen Man Shook Foundation Centre for Hepatitis Studies Deputy

More information

Herbal Supplements and the Liver. Lauren Myers PA-C, MMsc

Herbal Supplements and the Liver. Lauren Myers PA-C, MMsc Herbal Supplements and the Liver Lauren Myers PA-C, MMsc The Planner Lauren Myers, MMSc, PA-C - have no relevant financial relationships to disclose. Herbal Dietary Supplements in the US 42% of Americans

More information

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow R.J.Bailey MD Hepatocytes produce Proteins Clotting factors Hormones Bile Flow Trouble.. for the liver! Trouble for the Liver Liver Gall Bladder Common Alcohol Hep C Fatty Liver Cancer Drugs Viruses Uncommon

More information

Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?

Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need? Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need? Rob Goldin r.goldin@imperial.ac.uk Fatty liver disease Is there fatty

More information

4/27/2018. Disclosures LIVER FUNCTION TESTS LIVER FUNCTION TESTS LIVER FUNCTION TESTS APPROACH TO THE PATIENT WITH ABNORMAL LIVER TESTS

4/27/2018. Disclosures LIVER FUNCTION TESTS LIVER FUNCTION TESTS LIVER FUNCTION TESTS APPROACH TO THE PATIENT WITH ABNORMAL LIVER TESTS APPROACH TO THE PATIENT WITH ABNORMAL TESTS Kimberly A. Brown, M.D, FAST, FAASLD, AGAF Chief, Division of Gastroenterology and Hepatology Henry Ford Hospital Henry Ford Health System Detroit, Michigan

More information

Approach to the Patient with Liver Disease

Approach to the Patient with Liver Disease Approach to the Patient with Liver Disease Diagnosis of liver disease Careful history taking Physical examination Laboratory tests Radiologic examination and imaging studies Liver biopsy Liver diseases

More information

Drug Induced Liver Disease Role of the Pathologist. Disclosure. DILI can never be excluded. Romil Saxena, MD. Dr. Saxena has nothing to Disclose

Drug Induced Liver Disease Role of the Pathologist. Disclosure. DILI can never be excluded. Romil Saxena, MD. Dr. Saxena has nothing to Disclose Drug Induced Liver Disease Role of the Pathologist Romil Saxena, MD Disclosure Dr. Saxena has nothing to Disclose DILI can never be excluded #1 DILI has no specific pattern of injury it can mimic any and

More information

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver A Review of Liver Function Tests James Gray Gastroenterology Vancouver Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted

More information

Drug Induced Liver Injury (DILI)

Drug Induced Liver Injury (DILI) Drug Induced Liver Injury (DILI) Aisling Considine- Consultant Hepatology Pharmacist. King s College Hospital NHS Foundation Trust aislingconsidine@nhs.net Drug Induced Liver Injury /Disease Acute Liver

More information

I have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES

I have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES LIVER TESTS: HOW TO UTILIZE THEM I have no disclosures relevant to this presentation José Franco, MD Professor of Medicine, Surgery and Pediatrics Medical College of Wisconsin OBJECTIVES Differentiate

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Outline liver function tests / tests of

More information

Interpreting Liver Function Tests

Interpreting Liver Function Tests PSH Clinical Guidelines Statement 2017 Interpreting Liver Function Tests Dr. Asad A Chaudhry Consultant Hepatologist, Chaudhry Hospital, Gujranwala, Pakistan. Liver function tests (LFTs) generally refer

More information

Liver Disease That Presents with Jaundice (PBC, Alcohol and Drugs): Diagnosis and Patient Management. Emma Pham, PA-C

Liver Disease That Presents with Jaundice (PBC, Alcohol and Drugs): Diagnosis and Patient Management. Emma Pham, PA-C Liver Disease That Presents with Jaundice (PBC, Alcohol and Drugs): Diagnosis and Patient Management Emma Pham, PA-C Case: JL (jaundiced lady) A 72 year old woman presents to her primary care provider

More information

Serologic Markers CONVENTIONAL ANTIBODIES ANTIBODIES UNCONVENTIONAL. AIH Type I

Serologic Markers CONVENTIONAL ANTIBODIES ANTIBODIES UNCONVENTIONAL. AIH Type I Autoimmune Hepatitis By Thomas Frazier Objective What we need to know about AIH Diagnosis Treatment Difficulties in both Liver transplantation concerns AASLD Guidelines: Hepatology. 2010 Jun;51(6):2193-213.

More information

Drug Induced Liver Injury. Case. Case 8/8/2016. Donald Gardenier, DNP, FNP BC, FAAN, FAANP Desert Oasis Health Care Palm Springs, CA

Drug Induced Liver Injury. Case. Case 8/8/2016. Donald Gardenier, DNP, FNP BC, FAAN, FAANP Desert Oasis Health Care Palm Springs, CA Drug Induced Liver Injury Donald Gardenier, DNP, FNP BC, FAAN, FAANP Desert Oasis Health Care Palm Springs, CA Case 28 year old white male PMHx Grave s disease; Rx levothyroxine 175 mcg No recent travel

More information

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry MPharm Programme Liver Biochemistry Slide 1 of 49 MPHM Liver Biochemistry Learning Outcomes Assess and evaluate the signs and symptoms of illness Assess and critically appraise a patients medication regimen,

More information

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP Autoimmune hepatobiliary diseases The liver is an important target for immunemediated injury. Three disease phenotypes are recognized:

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Outline liver function / liver function

More information

Approach to Abnormal Liver Tests

Approach to Abnormal Liver Tests Approach to Abnormal Liver Tests Scott W. Biggins, MD, MAS Assistant Professor Division of Gastroenterology UCSF Scott.Biggins@ucsf.edu (Thanks to Hal Yee, MD) This Morning s Presentation Clinical vignettes

More information

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST IN THE NAME OF GOD AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL D r. MANIJE DEZFULI INFECTIOUS DISEASES SPECIALIST Acute Viral Hepatitis The Anatomy of the Liver Hepatic Physiology Liver: Largest solid organ

More information

HEPETIC SYSTEMS BIOCHEMICAL HEPATOCYTIC SYSTEM HEPATOBILIARY SYSTEM RETICULOENDOTHELIAL SYSTEM

HEPETIC SYSTEMS BIOCHEMICAL HEPATOCYTIC SYSTEM HEPATOBILIARY SYSTEM RETICULOENDOTHELIAL SYSTEM EVALUATION OF LIVER FUNCTION R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty HEPETIC SYSTEMS BIOCHEMICAL HEPATOCYTIC SYSTEM HEPATOBILIARY SYSTEM RETICULOENDOTHELIAL SYSTEM METABOLIC FUNCTION

More information

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust ABNORMAL LIVER FUNCTION TESTS Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust INTRODUCTION Liver function tests Cases Non invasive fibrosis measurement Questions UK MORTALITY RATE

More information

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries Paul Y. Kwo, MD, FACG, FAASLD 1, Stanley M. Cohen, MD, FACG, FAASLD 2, and Joseph K. Lim, MD, FACG, FAASLD 3 1 Division of Gastroenterology/Hepatology,

More information

Disclosures Drug-induced Acute Liver Failure

Disclosures Drug-induced Acute Liver Failure Disclosures Drug-induced Acute Liver Failure I have nothing to disclose. Raga Ramachandran, MD, PhD UCSF Pathology May 25, 2012 Acute liver failure (Fulminant hepatitis) Definition - onset of hepatic encephalopathy

More information

VIRAL HEPATITIS. Definitions. Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Acute Viral Hepatitis Symptoms

VIRAL HEPATITIS. Definitions. Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Acute Viral Hepatitis Symptoms Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Definitions AST and ALT Markers of hepatocellular injury Ryan M. Ford, MD Assistant Professor of Medicine Director of Viral Hepatitis

More information

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob: Hepatitis Dr. Mohamed. A. Mahdi Mob: 0123002800 5/2/2019 Hepatitis Hepatitis means the inflammation of the liver. May cause by viruses or bacteria, parasites, radiation, drugs, chemical and toxins (alcohol).

More information

Acute Hepatitis: An Approach to Infectious and Other Causes. Mary Anne Cooper MSc, MD, MEd, FRCPC

Acute Hepatitis: An Approach to Infectious and Other Causes. Mary Anne Cooper MSc, MD, MEd, FRCPC : An Approach to Infectious and Other Causes Mary Anne Cooper MSc, MD, MEd, FRCPC Faculty: Dr. Mary Anne Cooper Relationships with commercial interests: Consulting Fees: Lupin Pharmaceuticals, Canada Objectives

More information

A Rational Evidence-based Approach to Abnormal Liver Tests

A Rational Evidence-based Approach to Abnormal Liver Tests A Rational Evidence-based Approach to Abnormal Liver Tests Jane D. Ricaforte-Campos, MD FPCP, FPSG, FPSDE 2013 HSP Post-graduate Course Radisson Blu Hotel, Cebu City misnomer Liver Function Tests Does

More information

1. Based on A.S. s labs and presentation, what type of liver injury would you classify her as experiencing?

1. Based on A.S. s labs and presentation, what type of liver injury would you classify her as experiencing? Drug Induced Liver Injury Cases Case #1 A.S., a16 year-old female, was found by her pediatrician to be slightly jaundiced during a routine school physical. She denied any history of liver disease, abdominal

More information

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob: Diseases of liver Dr. Mohamed. A. Mahdi Mob: 0123002800 4/2/2019 Cirrhosis Cirrhosis is a complication of many liver disease. Permanent scarring of the liver. A late-stage liver disease. The inflammation

More information

British Liver Transplant Group Pathology meeting September Leeds cases

British Liver Transplant Group Pathology meeting September Leeds cases British Liver Transplant Group Pathology meeting September 2014 Leeds cases Leeds Case 1 Male 61 years Liver transplant for HCV cirrhosis with HCC in January 2014. Now raised ALT and bilirubin,? acute

More information

Disclosure. Evaluation of Abnormal Hepatic Enzymes

Disclosure. Evaluation of Abnormal Hepatic Enzymes Evaluation of Abnormal Hepatic Enzymes Bruce D. Askey, MS, ANP-BC Associate Lecturer North Andover, MA Adult Nurse Practitioner Dept. of Hepatology/Gastroenterology Guthrie Clinic Sayre, Pa Disclosure

More information

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured What Is Cirrhosis? Cirrhosis occurs when the liver is permanently scarred or injured by chronic conditions and diseases. Common causes of cirrhosis include: Long-term alcohol abuse. Chronic viral hepatitis

More information

Key Points: Autoimmune Liver Disease: Update for Pathologists from the Hepatologist s Perspective. Jenny Heathcote, MD. University of Toronto

Key Points: Autoimmune Liver Disease: Update for Pathologists from the Hepatologist s Perspective. Jenny Heathcote, MD. University of Toronto Autoimmune Liver Disease: Update for Pathologists from the Hepatologist s Perspective Jenny Heathcote, MD University of Toronto Key Points: AILD comprise autoimmune hepatitis, primary biliary cirrhosis

More information

WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT

WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT October 13, 2016 Reminder - treatment is recommended for all patients with chronic HCV infection Except short life expectancies that cannot be remediated

More information

Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane.

Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane. ISPUB.COM The Internet Journal of Anesthesiology Volume 25 Number 1 Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane. V Sampathi,

More information

Therapies for DILI: NAC, Steroids or NRF-2 activators?

Therapies for DILI: NAC, Steroids or NRF-2 activators? Therapies for DILI: NAC, Steroids or NRF-2 activators? William M. Lee, MD Professor of Internal Medicine Meredith Mosle Chair in Liver Diseases UT Southwestern Medical Center at Dallas Drug-Induced Liver

More information

Mrs Janet Catt. Pre-Conference Nurse s Course. Royal Free London NHS Foundation Trust. Janet Catt MSc RN Lead Nurse Specialist Practic 12/12/2014

Mrs Janet Catt. Pre-Conference Nurse s Course. Royal Free London NHS Foundation Trust. Janet Catt MSc RN Lead Nurse Specialist Practic 12/12/2014 Pre-Conference Nurse s Course in partnership with Mrs Janet Catt Royal Free London NHS Foundation Trust Janet Catt MSc RN Lead Nurse Specialist Practic 1 Liver blood tests monitoring cirrhosis HIV/HCV

More information

DILI PATHOLOGY. PHILIP KAYE November 2017 BSG Pathology Winter Meeting

DILI PATHOLOGY. PHILIP KAYE November 2017 BSG Pathology Winter Meeting DILI PATHOLOGY PHILIP KAYE November 2017 BSG Pathology Winter Meeting General Mechanisms Role of Liver Biopsy Outline Kleiner Categories Pathology! Differentials Severity Finally Drugs/Toxins may cause

More information

TB Case Management Hepatitis

TB Case Management Hepatitis TB Case Management Hepatitis Chris Keh, MD TB Controller, TB Prevention and Control Program, San Francisco Department of Public Health Assistant Clinical Professor, Division of Infectious Diseases, University

More information

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids Cholestasis Biochemical hallmark Impaired bile flow from liver to small intestine Alkaline phosphatase is primary

More information

Biochemical Investigations in Liver Disease. Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya

Biochemical Investigations in Liver Disease. Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya Biochemical Investigations in Liver Disease Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya Biochemical markers Albumin ALP ALT, AST Gamma-glutamyl transpeptidase

More information

Intrinsic vs. Idiosyncratic DILI

Intrinsic vs. Idiosyncratic DILI Idiosyncratic Drug Induced Liver Injury Naga Chalasani, MD, FACG Professor & Director Division of GI and Hepatology Indiana University School of Medicine Clarian/IU Digestive Diseases Center ACG PG Course

More information

-Liver function tests -

-Liver function tests - -Liver function tests - Biochimestry teamwork Osamah Al-Jarallah Abdulaziz Al-Shamlan Abdullah Al-Mazyad Turki Al-Otaibi Khalid Al-Khamis Saud Al-awad KhaledAlmohaimede Meshal Al-Otaibi Al-Anood Asiri

More information

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics Learning Outcomes Define biopharmaceutics Describe 4 processes of pharmacokinetics Describe factors that affect medication absorption Describe

More information

Autoimmune Hepatitis. Dr. Stefania Casu Hepatology, UVCM, Inselspital Bern. November 14th, 2018

Autoimmune Hepatitis. Dr. Stefania Casu Hepatology, UVCM, Inselspital Bern. November 14th, 2018 Autoimmune Hepatitis Dr. Stefania Casu Hepatology, UVCM, Inselspital Bern November 14th, 2018 AIH - Definition Manns MP J Hepatol 2015, vol 62, P 100-111 AIH - Definition Autoimmune hepatitis (AIH) is

More information

Drug therapy in patient with hepatic impairment

Drug therapy in patient with hepatic impairment Drug therapy in patient with hepatic impairment Arzneimitteltherapie bei Leberinsuffizienz Dominik Wilke 03/04 Mai 2018 43. ADKA-Kongress, Stuttgart Functions of the Liver I Metabolism (Carbohydrates,

More information

Drug Induced Liver Injury: A Clinical Perspective. Robert J. Fontana, MD

Drug Induced Liver Injury: A Clinical Perspective. Robert J. Fontana, MD Drug Induced Liver Injury: A Clinical Perspective Robert J. Fontana, MD Drug induced liver injury (DILI) is an uncommon cause of acute and chronic liver injury of increasing importance to patients, clinicians,

More information

Extrahepatic Biliary Obstruction. Ductal Diseases: Stones Tumors. Acute Injury: Viral Hepatitis Toxin (APAP/Etoh) Reye s Shock.

Extrahepatic Biliary Obstruction. Ductal Diseases: Stones Tumors. Acute Injury: Viral Hepatitis Toxin (APAP/Etoh) Reye s Shock. Extrahepatic Biliary Obstruction Stones Tumors Ductal Diseases: Ductal Diseases: Primary Biliary Primary Biliary Cirrhosis Cirrhosis Sclerosing Cholangitis Sclerosing Cholangitis Acute Injury: Viral Hepatitis

More information

July Hepatitis Monthly Awareness Toolkit

July Hepatitis Monthly Awareness Toolkit July Hepatitis Monthly Awareness Toolkit World Hepatitis Day is July 28 th Together we can eliminate Hepatitis across the globe!! Hepatitis Viral Hepatitis is an inflammation of the liver caused by a virus.

More information

Chapter 143 Acetaminophen

Chapter 143 Acetaminophen Chapter 143 Acetaminophen Episode overview 1) Describe the metabolism of Acetaminophen 2) Describe the 4 stages of Acetaminophen toxicity 3) List 4 mechanism of action of N-acetylcysteine 4) When do you

More information

Alpha-1 Liver Disease

Alpha-1 Liver Disease Alpha-1 Liver Disease Jeffrey Teckman, M.D. Professor of Pediatrics and Biochemistry Associate Chair of Pediatrics for Research Director, Pediatric Gastroenterology and Hepatology St. Louis University

More information

So, this is a group of patients that were treated with an anti-inflammatory drug in development within Eli Lilly. The name of the compound was an

So, this is a group of patients that were treated with an anti-inflammatory drug in development within Eli Lilly. The name of the compound was an Thank you, Mark and thank you all for being here and sticking with it. This is going to be a little bit of a detour to the left side of the first slide that Mark showed, which is a hypersensitivity allergic-type

More information

Histology. The pathology of the. bile ducts. pancreas. liver. The lecture in summary. Vt-2006

Histology. The pathology of the. bile ducts. pancreas. liver. The lecture in summary. Vt-2006 Vt-2006 The pathology of the liver, bile ducts and pancreas Richard Palmqvist Docent, ST-läkare, Klin Pat Lab, Labcentrum The lecture in summary Introduction, histology & physiology in brief General phenomenon

More information

LIVER SPECIALTY CONFERENCE USCAP Maha Guindi, M.D. Clinical Professor of Pathology Cedars-Sinai Medical Center Los Angeles, CA

LIVER SPECIALTY CONFERENCE USCAP Maha Guindi, M.D. Clinical Professor of Pathology Cedars-Sinai Medical Center Los Angeles, CA LIVER SPECIALTY CONFERENCE USCAP 2016 Maha Guindi, M.D. Clinical Professor of Pathology Cedars-Sinai Medical Center Los Angeles, CA Nothing to disclose Case History 47-year-old male, long standing ileal

More information

DRUG INDUCED LIVER INJURY DIPENDRA PARAJULI 02/02/2006. University of Louisville

DRUG INDUCED LIVER INJURY DIPENDRA PARAJULI 02/02/2006. University of Louisville DRUG INDUCED LIVER INJURY DIPENDRA PARAJULI 02/02/2006 EPIDEMIOLOGY - One of the most common forms of ADR - Responsible for - 3-10 % of all reported ADRs - Approx. 2 to 5 % of patients requiring hospitalization

More information

CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS

CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS Interpreting abnormal liver function tests (LFTs) and trying to diagnose any underlying liver disease is a common scenario in Primary

More information

Autoimmune hepatitis

Autoimmune hepatitis Autoimmune hepatitis: Autoimmune hepatitis a spectrum within a spectrum Alastair Burt Professor of Pathology and Dean of Clinical Medicine Newcastle University Spectrum of autoimmune liver disease Autoimmune

More information

Acute Liver Failure. Agenda. Natalie H Bzowej, MD, PhD, FRCPC. Case Introduction Definition Diagnosis Initial Laboratory Evaluation Acetaminophen NAC

Acute Liver Failure. Agenda. Natalie H Bzowej, MD, PhD, FRCPC. Case Introduction Definition Diagnosis Initial Laboratory Evaluation Acetaminophen NAC Acute Liver Failure Natalie H Bzowej, MD, PhD, FRCPC Agenda Case Introduction Definition Diagnosis Initial Laboratory Evaluation Acetaminophen NAC 1 Case 27 year old female presents to ER with N/V Denies

More information

Mr Ricky Gellissen Imperial College Healthcare NHS Trust, London, UK

Mr Ricky Gellissen Imperial College Healthcare NHS Trust, London, UK Mr Ricky Gellissen Imperial College Healthcare NHS Trust, London, UK Ms Sally Bufton University Hospital Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham Mrs Janet Catt Royal Free

More information

Chronic Hepatic Disease

Chronic Hepatic Disease Chronic Hepatic Disease 10 th Leading Cause of Death Liver Functions Energy Metabolism Protein Synthesis Solubilization, Transport, and Storage Protects and Clears drugs, damaged cells Causes of Liver

More information

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland Sanjiv Chopra, MD, MACP Professor of Medicine Harvard Medical School Editor In Chief Hepatology Section Up To Date Serum

More information

Clinical Dilemmas in Liver Disease

Clinical Dilemmas in Liver Disease Clinical Dilemmas in Liver Disease Primary Care Update: 2012 Rena K. Fox, M.D. Medical Editor, VA National Hepatitis C Website Associate Professor of Clinical Medicine, UCSF Outline What is the role of

More information

Biochemistry Liver Function Tests (LFTs)

Biochemistry Liver Function Tests (LFTs) HbA NH 2 H 2 O 2 KClO3 Cl 2 O 7 PO 4 CH2O NAOH KMnO 4 M E D I C I N E KING SAUD UNIVERSITY Co 2 COOH MgCl 2 H 2 O Important Extra Information Doctors slides Doctors notes SO 2 HCN CCl 4 CuCl 2 SiCl 4 Biochemistry

More information

Liver Cancer Causes, Risk Factors, and Prevention

Liver Cancer Causes, Risk Factors, and Prevention Liver Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for liver cancer.

More information

Approach to the Patient with Abnormal Liver Enzymes

Approach to the Patient with Abnormal Liver Enzymes Approach to the Patient with Abnormal Liver Enzymes Donald Gardenier, DNP, FNP-BC Assistant Professor and Clinical Program Director Icahn School of Medicine at Mount Sinai New York, NY Conflict of Interest

More information

CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease

CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease Maria Isabel Fiel, M.D. The Mount Sinai Medical Center New York, New York Case A 57 yo man, 7 months

More information

World Health Organization. Western Pacific Region

World Health Organization. Western Pacific Region Basic modules for hepatitis 1 Basic Module 1 Liver anatomy and physiology 2 Position of liver Midline Located in right upper abdomen Protected by the right rib cage Right upper Measures: 12 15 cm in vertical

More information

Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology

Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology Nonalcoholic steatohepatitis and Fatty Liver Disease Liver manifestations of the obesity epidemic Changes

More information

Paul Martin, MD, FACG. University of Miami. 30,000 deaths from cirrhosis per annum, alcohol implicated in 48%

Paul Martin, MD, FACG. University of Miami. 30,000 deaths from cirrhosis per annum, alcohol implicated in 48% Paul Martin, MD, FACG University of Miami 30,000 deaths from cirrhosis per annum, alcohol implicated in 48% Second commonest indication for liver transplant NIAA 2007 Page 1 of 26 Risk Factors Medical

More information

Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy

Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy Goals Share an interesting case Important because it highlights a common problem that we re likely to

More information

Spring 2017 Health & Wellness Seminar Series. Seminar 1: April 25 th, 2017

Spring 2017 Health & Wellness Seminar Series. Seminar 1: April 25 th, 2017 Spring 2017 Health & Wellness Seminar Series Seminar 1: April 25 th, 2017 1 Breakthroughs in Screening & Treatment of Liver Disease: From Hepatitis C and Fatty Liver Disease to Liver Cancer Robert S. Brown,

More information

Table 1 Some of the drugs that induce DILI and the mechanisms underlying their toxicity

Table 1 Some of the drugs that induce DILI and the mechanisms underlying their toxicity Table 1 Some of the drugs that induce DILI and the mechanisms underlying their toxicity. 54 78 Drug Use Possible mechanism of liver injury Liver injury type Abacavir Acetaminophe n Aspirin Interferon beta

More information

Drug-, herb- and dietary supplement-induced liver injury

Drug-, herb- and dietary supplement-induced liver injury Special article Arch Argent Pediatr 2017;115(6):e397-e403 / e397 Drug-, herb- and dietary supplement-induced liver injury María L. Cavalieri, M.D. a and Daniel D Agostino, M.D. a a. Department of Pediatric

More information

Pittsburgh CME Conference November 7-9, 2014

Pittsburgh CME Conference November 7-9, 2014 Disclosures: Pennsylvania Academy of Family Physicians Foundation Pittsburgh CME Conference November 7-9, 2014 Abnormal LFT s Now What? (Patient Safety) Bruce Gebhardt, MD St. Vincent Health System, Erie,

More information

Liver Disease. By: Michael Martins

Liver Disease. By: Michael Martins Liver Disease By: Michael Martins Recently I have been getting a flurry of patients that have some serious liver complications. This week s literature review will be the dental management of the patients

More information

Drug-Induced Liver Injury

Drug-Induced Liver Injury SUPPLEMENT ARTICLE Drug-Induced Liver Injury Neil Kaplowitz Gastroenterology/Liver Division, Keck School of Medicine, University of Southern California, Los Angeles Drug-induced hepatotoxicity is a frequent

More information

PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES I HAVE NOTHING TO DISCLOSE CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017

PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES I HAVE NOTHING TO DISCLOSE CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017 CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017 I HAVE NOTHING TO DISCLOSE Linda Ferrell PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES Linda Ferrell, MD, UCSF THE PROBLEM

More information

AASLD Immune tolerant phase HBV NAFLD diagnostic HCC

AASLD Immune tolerant phase HBV NAFLD diagnostic HCC AASLD 2016 Immune tolerant phase HBV NAFLD diagnostic HCC Immune tolerant 3 Modified from Chan HLY and Wong VWS. Hepatitis B. In Zakim and Boyers s Hepatology 2012 2015 AMERICAN ASSOCIATION FOR THE S1T6UDY

More information

Primary Sclerosing Cholangitis Medical Management

Primary Sclerosing Cholangitis Medical Management Primary Sclerosing Cholangitis Medical Management Kapil Chopra M.D. Assistant Professor of Medicine Division of Transplant Medicine Mayo Clinic Arizona PSC Primary sclerosing cholangitis is a progressive

More information

SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less. For pack sizes of more than 24 tablets

SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less. For pack sizes of more than 24 tablets SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less S1 For pack sizes of more than 24 tablets PROPRIETARY NAME: AND DOSAGE FORM PANADO MELTABS (Tablets) COMPOSITION: Each tablet contains 500 mg

More information

Autoimmune Hepatitis in Clinical Practice

Autoimmune Hepatitis in Clinical Practice 1 Autoimmune Hepatitis in Clinical Practice Atif Zaman, MD MPH Professor of Medicine Senior Associate Dean for Clinical and Faculty Affairs School of Medicine Oregon Health & Science University Disclosure

More information

Management of Alcoholic Liver Disease. Hafez Fakheri Professor of medicine, Sari, Iran

Management of Alcoholic Liver Disease. Hafez Fakheri Professor of medicine, Sari, Iran Management of Alcoholic Liver Disease Hafez Fakheri Professor of medicine, Sari, Iran Alcoholic Hepatitis Scores DF = (4.6 x [ PT- control PT]) + (bili ) MELD = 10 * ((0.957 * ln(cr)) + (0.378 * ln(bil))

More information

Recent Status of Drug-induced Liver Injury and Its Problems in Japan

Recent Status of Drug-induced Liver Injury and Its Problems in Japan Research and Reviews Recent Status of Drug-induced Liver Injury and Its Problems in Japan JMAJ 53(4): 243 247, 2010 Hajime TAKIKAWA* 1 Abstract Adverse drug reactions are becoming a social issue in recent

More information

Primary Biliary Cholangitis

Primary Biliary Cholangitis Primary Biliary Cholangitis What is primary biliary cholangitis? Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic liver disease. When a person has PBC, the immune

More information

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP-BC Introduction (https://www.srtr.org) What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC

More information

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC Introduction (https://www.srtr.org) 1 What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC

More information

Dietary supplementation in treating non-alcoholic fatty liver disease Dr. Ahmad Saedi Associate Professor School of Nutritional Sciences and

Dietary supplementation in treating non-alcoholic fatty liver disease Dr. Ahmad Saedi Associate Professor School of Nutritional Sciences and Dietary supplementation in treating non-alcoholic fatty liver disease Dr. Ahmad Saedi Associate Professor School of Nutritional Sciences and Dietetics Tehran University of Medical Sciences Honorary Academic

More information

Anaemia Pathway. Anaemia. Type of Anaemia Check Haematinics (Iron stores,b12,folate) Fit for endoscopies. endoscopies yes no. Non Iron Deficient

Anaemia Pathway. Anaemia. Type of Anaemia Check Haematinics (Iron stores,b12,folate) Fit for endoscopies. endoscopies yes no. Non Iron Deficient Cognitive if unable to consent, must attend clinic with next of kin to act as advocate. Rockwood Frailty Score 6 consider appropriate referral to elderly care. See attachment Anaemia Pathway Anaemia Type

More information

Chronic Liver Disease after Acute Hepatocellular DILI

Chronic Liver Disease after Acute Hepatocellular DILI Chronic Liver Disease after Acute Hepatocellular DILI Robert J. Fontana, MD University of Michigan Medical Center DILI Natural history of acute DILI Transplant/ death Chronic DILI Chronic DILI Incidence

More information

NON-ALCOHOLIC FATTY LIVER DISEASE:

NON-ALCOHOLIC FATTY LIVER DISEASE: NON-ALCOHOLIC FATTY LIVER DISEASE: ROLE OF THE PRIMARY PROVIDER Archita P. Desai, MD Assistant Professor of Medicine University of Arizona 25 th Annual Southwestern Conference on Medicine Outline Pathophysiology

More information

Should There Be a Standard of Care (SOC) for Drug-Induced Liver Injury (DILI)? Leonard B Seeff, MD

Should There Be a Standard of Care (SOC) for Drug-Induced Liver Injury (DILI)? Leonard B Seeff, MD Should There Be a Standard of Care (SOC) for Drug-Induced Liver Injury (DILI)? Leonard B Seeff, MD Drug-Induced Liver Injury: Are We Ready to Look? March 23-24,2011 AASLD, FDA/CDER, PhRMA A Common Statement

More information

CrackCast Episode 28 Jaundice

CrackCast Episode 28 Jaundice CrackCast Episode 28 Jaundice Episode overview: 1) Describe heme metabolism 2) List common pre-hepatic/hepatic/post-hepatic causes of jaundice Wisecracks: 1) What are clinical signs of liver disease? 2)

More information

Hepatitis C Information Sheet.

Hepatitis C Information Sheet. Department of Gastroenterology 4225 Hoyt Avenue, Suite A Everett, Washington 98203-2318 (425) 259-3122 * (425) 252-9860 fax Hepatitis C Information Sheet. What you should know about having HCV infection:

More information

Doc, is it good for my liver?

Doc, is it good for my liver? Victor J. Navarro, MD, FAASLD Herbal and Dietary Supplements Doc, is it good for my liver? Postgraduate Course: Challenges in Management of Common Liver Diseases 188 1 o Chief Complaint A 45 year old male

More information

Chapter 11. Major Characteristics of CAM. Research. CAM Healing Methods. Complementary and Alternative Medicine (CAM) CAM Healing Methods (continued)

Chapter 11. Major Characteristics of CAM. Research. CAM Healing Methods. Complementary and Alternative Medicine (CAM) CAM Healing Methods (continued) Chapter 11 Herbal and Alternative Therapies Complementary and Alternative Medicine (CAM) Considered outside mainstream health care Upper Saddle River, New Jersey 07458 All rights reserved. Major Characteristics

More information

Liver Function Tests. Dr. Abdulhussien Aljebory Babylon university College of Pharmacy

Liver Function Tests. Dr. Abdulhussien Aljebory Babylon university College of Pharmacy Liver Function Tests Dr. Abdulhussien Aljebory Babylon university College of Pharmacy FUNCTIONS OF LIVER Metabolic function Excretory function Synthetic fuction Detoxification function Storage function

More information